These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22122678)

  • 1. Twenty years of Alzheimer's disease-causing mutations.
    Goate A; Hardy J
    J Neurochem; 2012 Jan; 120 Suppl 1():3-8. PubMed ID: 22122678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis--20 years on'.
    Checler F; Turner AJ
    J Neurochem; 2012 Jan; 120 Suppl 1():iii-iv. PubMed ID: 22182264
    [No Abstract]   [Full Text] [Related]  

  • 3. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
    Jonsson T; Atwal JK; Steinberg S; Snaedal J; Jonsson PV; Bjornsson S; Stefansson H; Sulem P; Gudbjartsson D; Maloney J; Hoyte K; Gustafson A; Liu Y; Lu Y; Bhangale T; Graham RR; Huttenlocher J; Bjornsdottir G; Andreassen OA; Jönsson EG; Palotie A; Behrens TW; Magnusson OT; Kong A; Thorsteinsdottir U; Watts RJ; Stefansson K
    Nature; 2012 Aug; 488(7409):96-9. PubMed ID: 22801501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amyloid in the pathogenesis of Alzheimer's disease.
    Verbeek MM; Ruiter DJ; de Waal RM
    Biol Chem; 1997 Sep; 378(9):937-50. PubMed ID: 9348103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piecing together Alzheimer's.
    St George-Hyslop PH
    Sci Am; 2000 Dec; 283(6):76-83. PubMed ID: 11103462
    [No Abstract]   [Full Text] [Related]  

  • 6. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
    Tanzi RE; Bertram L
    Cell; 2005 Feb; 120(4):545-55. PubMed ID: 15734686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of Alzheimer's β-amyloid precursor protein.
    Zhang H; Ma Q; Zhang YW; Xu H
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):9-21. PubMed ID: 22122372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the beta-amyloid precursor protein in Alzheimer's disease.
    Ashall F; Goate AM
    Trends Biochem Sci; 1994 Jan; 19(1):42-6. PubMed ID: 8140621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
    Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity of gene defects responsible for familial Alzheimer disease.
    Tanzi R; Gaston S; Bush A; Romano D; Pettingell W; Peppercorn J; Paradis M; Gurubhagavatula S; Jenkins B; Wasco W
    Genetica; 1993; 91(1-3):255-63. PubMed ID: 8125274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shutting down Alzheimer's.
    Wolfe MS
    Sci Am; 2006 May; 294(5):72-9. PubMed ID: 16708491
    [No Abstract]   [Full Text] [Related]  

  • 16. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
    Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
    Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis.
    Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV
    ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's dementia and amyloid precursor-protein].
    Blom N; Linnemann D
    Ugeskr Laeger; 1992 Apr; 154(15):1010-5. PubMed ID: 1566508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease aetiology: amyloid and chromosome 14.
    Houlden H; Mullan M
    Br J Hosp Med; 1993 Apr 21-May 4; 49(8):535-6. PubMed ID: 8508237
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
    Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
    Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.